CervoMed Inc. (CRVO) stock
CRVONasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.50−0.17 (-10.18%)
Close on Nov 17, 2026Market cap $22.68MP/E –Yield –
CervoMed cash
Cash and short-term investments held at the end of each period.
CervoMed's cash was $24.90M at Jun 30, 2026. For fiscal 2025 it was $20.90M, down 46.3% from the year before. Over ten years it grew 26.5% a year on average. The highest annual figure on record is $38.92M in fiscal 2024.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $20.90M | -46.3% |
| FY2024 | Dec 31, 2024 | $38.92M | +399.5% |
| FY2023 | Dec 31, 2023 | $7.79M | -52.8% |
| FY2022 | Dec 31, 2022 | $16.50M | +147.5% |
| FY2021 | Dec 31, 2021 | $6.67M | -64.0% |
| FY2020 | Dec 31, 2020 | $18.52M | +30.6% |
| FY2019 | Dec 31, 2019 | $14.18M | +77.4% |
| FY2018 | Dec 31, 2018 | $7.99M | -10.2% |
| FY2017 | Dec 31, 2017 | $8.90M | +472.9% |
| FY2016 | Dec 31, 2016 | $1.55M | -22.2% |
| FY2015 | Dec 31, 2015 | $2.00M | -14.5% |
| FY2014 | Dec 31, 2014 | $2.34M | +816.4% |
| FY2013 | Dec 31, 2013 | $254.96K | -18.3% |
| FY2012 | Dec 31, 2012 | $312.09K | +217.0% |
| FY2011 | Dec 31, 2011 | $98.45K | – |
| FY2010 | Dec 31, 2010 | $0 | – |
| FY2009 | Dec 31, 2009 | $0 | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $24.90M | -25.7% |
| Q1 FY2026 | Mar 31, 2026 | $12.90M | -63.4% |
| Q4 FY2025 | Dec 31, 2025 | $20.90M | -46.3% |
| Q3 FY2025 | Sep 30, 2025 | $27.30M | -41.5% |
| Q2 FY2025 | Jun 30, 2025 | $33.50M | -25.7% |
| Q1 FY2025 | Mar 31, 2025 | $35.24M | +453.4% |
| Q4 FY2024 | Dec 31, 2024 | $38.92M | +399.5% |
| Q3 FY2024 | Sep 30, 2024 | $46.66M | +347.6% |
| Q2 FY2024 | Jun 30, 2024 | $45.09M | +6839.5% |
| Q1 FY2024 | Mar 31, 2024 | $6.37M | +13.7% |
| Q4 FY2023 | Dec 31, 2023 | $7.79M | -52.8% |
| Q3 FY2023 | Sep 30, 2023 | $10.42M | -56.7% |
| Q2 FY2023 | Jun 30, 2023 | $649.78K | -97.7% |
| Q1 FY2023 | Mar 31, 2023 | $5.60M | -82.8% |
| Q4 FY2022 | Dec 31, 2022 | $16.50M | +147.5% |
| Q3 FY2022 | Sep 30, 2022 | $24.06M | -40.4% |
| Q2 FY2022 | Jun 30, 2022 | $28.54M | -34.1% |
| Q1 FY2022 | Mar 31, 2022 | $32.55M | -30.2% |
| Q4 FY2021 | Dec 31, 2021 | $6.67M | -64.0% |
| Q3 FY2021 | Sep 30, 2021 | $40.34M | +84.1% |
| Q2 FY2021 | Jun 30, 2021 | $43.31M | +69.4% |
| Q1 FY2021 | Mar 31, 2021 | $46.63M | +330.7% |
| Q4 FY2020 | Dec 31, 2020 | $18.52M | +30.6% |
| Q3 FY2020 | Sep 30, 2020 | $21.91M | +256.9% |
| Q2 FY2020 | Jun 30, 2020 | $25.56M | +205.3% |
| Q1 FY2020 | Mar 31, 2020 | $10.83M | +103.0% |
| Q4 FY2019 | Dec 31, 2019 | $14.18M | +77.4% |
| Q3 FY2019 | Sep 30, 2019 | $6.14M | -44.3% |
| Q2 FY2019 | Jun 30, 2019 | $8.37M | -35.3% |
| Q1 FY2019 | Mar 31, 2019 | $5.33M | -67.1% |
| Q4 FY2018 | Dec 31, 2018 | $7.99M | -10.2% |
| Q3 FY2018 | Sep 30, 2018 | $11.02M | +806.1% |
| Q2 FY2018 | Jun 30, 2018 | $12.93M | +74.5% |
| Q1 FY2018 | Mar 31, 2018 | $16.20M | +32.7% |
| Q4 FY2017 | Dec 31, 2017 | $8.90M | +472.9% |
| Q3 FY2017 | Sep 30, 2017 | $1.22M | -59.8% |
| Q2 FY2017 | Jun 30, 2017 | $7.41M | – |
| Q1 FY2017 | Mar 31, 2017 | $12.21M | – |
| Q4 FY2016 | Dec 31, 2016 | $1.55M | – |
| Q3 FY2016 | Sep 30, 2016 | $3.02M | – |
See a number that looks wrong?